Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies

被引：0
|
作者：
Nissen, Francis [1 ]
Humbert, Marc [2 ,3 ,4 ]
Gibson, Peter [5 ]
Kostikas, Konstantinos [6 ]
Jaumont, Xavier [1 ]
Tassinari, Paolo [1 ]
Pfister, Pascal [1 ]
Bousquet, Jean [7 ,8 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Univ Paris Sud, Paris, France
[3] Hop Kremlin Bicetre, Serv Pneumol, Paris, France
[4] INSERM, UMR S999, Paris, France
[5] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW, Australia
[6] Univ Ioannina, Sch Med, Dept Resp Med, Ioannina, Greece
[7] INSERM, U1168, VIMA Ageing & Chron Dis Epidemiol & Publ Hlth App, Villejuif, France
[8] Univ Versailles St Quentin En Yvelines, UMR S 1168, Montigny Le Bretonneux, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; -; management; Severe asthma; Exacerbation;
D O I：
10.1183/13993003.congress-2019.PA2549
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2549
引用
收藏
页数：3
相关论文
共 50 条
  • [1] OMALIZUMAB REDUCES MAINTENANCE ORAL CORTICOSTEROID USE IN PATIENTS WITH SEVERE PERSISTENT ALLERGIC ASTHMA
    Niven, R.
    Molimard, M.
    Buhl, R.
    Le Gros, V.
    Thielen, A.
    Thirlwell, J.
    Maykut, R.
    THORAX, 2009, 64 : A130 - A130
  • [2] Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data
    Molimard, M.
    Buhl, R.
    Niven, R.
    Le Gros, V.
    Thielen, A.
    Thirlwell, J.
    Maykut, R.
    Peachey, G.
    RESPIRATORY MEDICINE, 2010, 104 (09) : 1381 - 1385
  • [3] Review: Omalizumab added to corticosteroids reduces exacerbations and corticosteroid use in adults and children with asthma
    Thien, Francis
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (10)
  • [4] Omalizumab Reduces Corticosteroid Use in Patients with Severe Allergic Asthma: Real-Life Experience in Israel
    Rottem, Menachem
    JOURNAL OF ASTHMA, 2012, 49 (01) : 78 - 82
  • [5] Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients
    Siergiejko, Zenon
    Swiebocka, Ewa
    Smith, Nicola
    Peckitt, Clare
    Leo, Jo
    Peachey, Guy
    Maykut, Robert
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (11) : 2223 - 2228
  • [6] Omalizumab: A Review of its Use in Patients with Severe Persistent Allergic Asthma
    McKeage, Kate
    DRUGS, 2013, 73 (11) : 1197 - 1212
  • [7] Omalizumab: A Review of its Use in Patients with Severe Persistent Allergic Asthma
    Kate McKeage
    Drugs, 2013, 73 : 1197 - 1212
  • [8] Dupilumab Reduces Oral Corticosteroid Use and Severe Exacerbations and Improves Lung Function in Patients With Oral Corticosteroid-Dependent Severe Asthma With and Without Comorbid Allergic Rhinitis in the Phase 3 LIBERTY ASTHMA VENTURE Study
    Castro, Mario
    Maspero, Jorge
    Sher, Lawrence
    Rabe, Klaus
    Casale, Thomas
    Rice, Megan
    Ruddy, Marcella
    Rowe, Paul
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB173 - AB173
  • [9] Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
    Szefler, Stanley
    Antonova, Jenya
    Trzaskoma, Benjamin
    Ortiz, Benjamin
    Paknis, Brandee
    Iqbal, Ahmar
    Goldstein, Stanley
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [10] Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies
    Luigi La Via
    Filippo Sanfilippo
    Giuseppe Cuttone
    Veronica Dezio
    Monica Falcone
    Serena Brancati
    Claudia Crimi
    Marinella Astuto
    European Journal of Clinical Pharmacology, 2022, 78 : 1613 - 1622
12345